Pulse Biosciences (PLSE) Short-term Investments (2016 - 2020)

Pulse Biosciences' Short-term Investments history runs 5 years deep, the most recent figure standing at $8.0 million for Q4 2020.

• On a quarterly basis, Short-term Investments fell 56.69% year-over-year to $8.0 million in Q4 2020; TTM through Dec 2020 was $8.0 million, a 56.69% decrease from a year earlier, with the FY2020 full-year figure at $8.0 million, down 56.69% from the prior year.
• Short-term Investments retreated to $8.0 million in Q4 2020 per PLSE's latest filing, from $22.5 million in the prior quarter.
• Across five years, Short-term Investments topped out at $44.3 million in Q1 2019 and bottomed at $495000.0 in Q2 2016.
• The 5-year median for Short-term Investments is $15.4 million (2017), against an average of $17.9 million.
• Across the five-year window, Short-term Investments jumped 2608.89% in 2017 and plunged 81.88% in 2020, its largest moves.
• Year by year, Short-term Investments stood at $14.3 million in 2016, then soared by 110.37% to $30.1 million in 2017, then slumped by 71.82% to $8.5 million in 2018, then surged by 118.15% to $18.5 million in 2019, then tumbled by 56.69% to $8.0 million in 2020.
• Per Business Quant, the three latest PLSE Short-term Investments figures stand at $8.0 million (Q4 2020), $22.5 million (Q3 2020), and $8.0 million (Q1 2020).